Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-26

FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Invega Sustenna (paliperidone palmitate) filed by Janssen Pharmaceuticals, Inc. The approval updates the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVEGA SUSTENNA (PALIPERIDONE PALMITATE)

Snippet

SUPPL AP for INVEGA SUSTENNA (PALIPERIDONE PALMITATE)